Literature DB >> 7735166

Effect of "co-ligand" on the biodistribution of 99mTc-labeled hydrazino nicotinic acid derivatized chemotactic peptides.

J W Babich1, A J Fischman.   

Abstract

Hydrazinonicotinamide (HYNIC) derivatized chemotactic peptides radiolabeled with 99mTc- (via 99mTc-glucoheptonate) have been demonstrated to be useful for infection imaging [J. Nucl. Med. 34, 1964-1974 (1993)]. Since HYNIC can occupy only two sites of the technetium co-ordination sphere, the labeled product most probably contains additional ligands. Thus we hypothesized that glucoheptonate serves this role by acting as a "'co-ligand'". Due to the low molecular weight of the chemotactic peptides, the "co-ligand" used for technetium labeling could have profound effects on biodistribution. To evaluate this possibility, we measured the biodistribution of 99mTc-labeled For-MLFK-HYNIC radiolabeled using four different "co-ligand"s: glucarate, glucoheptonate, mannitol and glucamine, providing a small series of hydroxyl-backbone ligands which differ in the number and type of ionizable functional groups present. Each preparation was injected into groups of 6 rats (approximately 10 microCi/rat) and biodistribution was determined at 5, 30, 60 and 120 min. Although small differences in biodistribution were detected in most tissues, the most prominent differences (P < 0.01) were observed in lung (glucoheptonate, glucarate > mannitol >> glucamine), liver (glucarate, glucoheptonate, mannitol >> glucamine), kidney (mannitol > glucarate, glucoheptonate, glucamine), spleen (glucarate >> glucoheptonate, mannitol >> glucamine) and GI-tract (glucarate, glucamine >> gluco-heptonate >> mannitol). These results provide support for the "co-ligand" hypothesis and indicate that the nature of the "co-ligand" can have profound effects on biodistribution. Although radiolabeling using glucamine as the "co-ligand" results in the lowest concentrations of radioactivity in most organs, the extremely low concentration of mannitol-labeled peptide in the GI-tract suggests that this may be the "co-ligand" of choice for most applications.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7735166     DOI: 10.1016/0969-8051(94)00081-t

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  12 in total

1.  Syntheses and structural characterization of rhenium-bis-hydrazinopyrimidine core complexes with thiolate and Schiff base coligands.

Authors:  Frank J Femia; Xiaoyuan Chen; Kevin P Maresca; John W Babich; Jon Zubieta
Journal:  Inorganica Chim Acta       Date:  2000-12-15       Impact factor: 2.545

2.  A novel ternary ligand system useful for preparation of cationic (99m)Tc-diazenido complexes and (99m)Tc-labeling of small biomolecules.

Authors:  Young-Seung Kim; Zhengjie He; Wen-Yuan Hsieh; Shuang Liu
Journal:  Bioconjug Chem       Date:  2006 Mar-Apr       Impact factor: 4.774

Review 3.  Labeling biomolecules with radiorhenium: a review of the bifunctional chelators.

Authors:  Guozheng Liu; Donald J Hnatowich
Journal:  Anticancer Agents Med Chem       Date:  2007-05       Impact factor: 2.505

Review 4.  Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides.

Authors:  Shuang Liu
Journal:  Adv Drug Deliv Rev       Date:  2008-04-23       Impact factor: 15.470

5.  Synthesis and crystal and molecular structure of a tetranuclear cluster based on the rhenium(III)-bisorganohydrazino core: [Re(HNNC(4)H(3)N(2))(NNC(4)H(3)N(2))(OCH(3))(2)](4).

Authors:  Frank J Femia; Xiaoyuan Chen; Kevin P Maresca; John W Babich; Jon Zubieta
Journal:  Inorganica Chim Acta       Date:  2000-09-01       Impact factor: 2.545

6.  Rapid noninvasive detection of experimental atherosclerotic lesions with novel 99mTc-labeled diadenosine tetraphosphates.

Authors:  D R Elmaleh; J Narula; J W Babich; A Petrov; A J Fischman; B A Khaw; E Rapaport; P C Zamecnik
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-20       Impact factor: 11.205

7.  Coligand effects on the solution stability, biodistribution and metabolism of the (99m)Tc-labeled cyclic RGDfK tetramer.

Authors:  Shuang Liu; Young-Seung Kim; Wen-Yuan Hsieh; Subramanya Gupta Sreerama
Journal:  Nucl Med Biol       Date:  2007-11-19       Impact factor: 2.408

8.  Evaluation of K(HYNIC)(2) as a bifunctional chelator for (99m)Tc-labeling of small biomolecules.

Authors:  Shundong Ji; Yang Zhou; Guoqiang Shao; Shuang Liu
Journal:  Bioconjug Chem       Date:  2013-04-08       Impact factor: 4.774

9.  Synthesis and preliminary evaluation of a new (99m)tc labeled substance p analogue as a potential tumor imaging agent.

Authors:  Saeed Mozaffari; Mostafa Erfani; Davood Beiki; Fariba Johari Daha; Farzad Kobarfard; Saeed Balalaie; Babak Fallahi
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

10.  A 99mTc-tricine-HYNIC-labeled Peptide Targeting the Melanocortin-1 Receptor for Melanoma Imaging.

Authors:  Danial Shamshirian; Mostafa Erfani; Davood Beiki; Maliheh Hajiramazanali; Babak Fallahi
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.